| A comparative study of the sarcopenia screening in older patients with interstitial lung disease M Hanada, N Sakamoto, H Ishimoto, T Kido, T Miyamura, M Oikawa, ... BMC Pulmonary Medicine 22 (1), 45, 2022 | 16 | 2022 |
| Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator … T Koga, S Sato, J Miyamoto, N Hagimori, Y Kawazoe, K Arinaga, ... Trials 19, 1-9, 2018 | 10 | 2018 |
| The effect of luseogliflozin on bone microarchitecture in older patients with type 2 diabetes: study protocol for a randomized controlled pilot trial using second-generation … A Haraguchi, R Shigeno, I Horie, S Morimoto, A Ito, K Chiba, Y Kawazoe, ... Trials 21, 1-9, 2020 | 6 | 2020 |
| Association between preoperative toe perfusion index and maternal core temperature decrease during cesarean delivery under spinal anesthesia: a prospective cohort study S Kaneko, K Hara, S Sato, T Nakashima, Y Kawazoe, M Taguchi, S Urabe, ... BMC anesthesiology 21, 1-9, 2021 | 4 | 2021 |
| Switching from Originator Infliximab to Biosimilar Infliximab in Japanese patients with rheumatoid arthritis achieving clinical remission (the IFX-SIRIUS study I): study … S Kawashiri, T Shimizu, S Sato, S Morimoto, Y Kawazoe, R Sumiyoshi, ... Medicine 99 (30), e21151, 2020 | 3 | 2020 |
| Effects of the attachment method of the stimulating electrodes Nihon-Kohden NM-345Y™ and changes in forearm position on stimulus current values during calibration in … M Makino, S Kaneko, S Sato, Y Kawazoe, T Ichinomiya, H Murata, ... Journal of Anesthesia 37 (6), 888-895, 2023 | 1 | 2023 |
| Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib … T Shimizu, S Kawashiri, S Morimoto, Y Kawazoe, S Kuroda, R Kawasaki, ... Trials 24 (1), 161, 2023 | 1 | 2023 |
| Comparison design and evaluation power in cohort and self-controlled case series designs for post-authorization vaccine safety studies S Sato, Y Kawazoe, T Katsuta, H Fukuda PeerJ 12, e16780, 2024 | | 2024 |
| Immune thrombocytopenic purpura and Guillain-Barré syndrome after 23-valent pneumococcal polysaccharide vaccination in Japan: The vaccine effectiveness, networking, and … S Sato, T Katsuta, Y Kawazoe, M Takahashi, F Murata, M Maeda, ... Vaccine 42 (1), 4-7, 2024 | | 2024 |
| STUDY PROTOCOL T Shimizu, S Kawashiri, S Morimoto, Y Kawazoe, S Kuroda, R Kawasaki, ... | | 2023 |
| Effectiveness of BNT162b2 against infection, symptomatic infection, and hospitalization among older adults aged≥ 65 years during the Delta variant predominance in Japan: The … W Mimura, C Ishiguro, J Terada-Hirashima, N Matsunaga, S Sato, ... Journal of Epidemiology, JE20230106, 2023 | | 2023 |
| AB0157 EFFICACY AND SAFETY OF FILGOTINIB IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE: COMPARATIVE STUDY WITH FILGOTINIB AND TOCILIZUMAB … T Shimizu, SY Kawashiri, S Morimoto, Y Kawazoe, S Kuroda, R Kawasaki, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 1209-1209, 2022 | | 2022 |
| Discontinuation of methotrexate in rheumatoid arthritis patients achieving clinical remission by treatment with upadacitinib plus methotrexate (DOPPLER study): A study protocol … T Shimizu, S Kawashiri, S Sato, Y Kawazoe, S Kuroda, R Kawasaki, Y Ito, ... Medicine 101 (2), e28463, 2022 | | 2022 |
| A comparative study of the sarcopenia screening in older patients with interstitial lung M Hanada, N Sakamoto, H Ishimoto, T Kido, T Miyamura, M Oikawa, ... | | 2022 |
| Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS … T Shimizu, SY Kawashiri, S Sato, S Morimoto, S Minoda, Y Kawazoe, ... Medicine 99 (32), e21480, 2020 | | 2020 |
| Rheumatoid arthritis-prognosis, predictors and outcome T Shimizu, SY Kawashiri, S Morimoto, Y Kawazoe, S Kuroda, R Kawasaki, ... Rheumatology (Oxford) 58 (1), i4-i16, 2019 | | 2019 |
| CA-50 and CA-19.9 as Tumour Markers: Which is Preferable? F. MARECHAL, G. BERTHIOT, M.-G. LEGRAND, H. LARBRE, A. CATTAN, G. DELTOUR (Reims, France) Radiation Chemistry of Cis … TT MITSUDOMI, S KANEKO, M TATEISHI, T YANO, T ISHIDA, S KOHNOE, ... Anticancer Research 10 (4-6), 1102, 1990 | | 1990 |
